Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

Clinical trial NCT05897541 · COMPLETED

Trial details

NCT number: NCT05897541
Sponsor: Shionogi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2023-06-09
Primary completion: 2024-08-30
Enrollment: 2387

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.